Related Experiment Video
Updated: Mar 8, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Curative surgery for gastric cancer in a patient with an implantable left ventricular assist device
Yuki Nakamura1, Koichi Toda1, Teruya Nakamura1
1Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-15 Yamada-Oka, Suita, Osaka, 565-0871, Japan.
Abstract:
The number of patients with end-stage heart failure treated by a left ventricular assist device (LVAD) is dramatically increasing, because the LVAD has been widely accepted for its clinical results. According to the initiation of destination therapy, the prevalence of malignancy in patients with an LVAD is estimated to increase. In patients with LVADs, abdominal surgery for visceral malignancy is associated with technical difficulties because of the presence of an LVAD pump or the driveline which is located transversely in the preperitoneal space. Herein, we describe the technical management for complete resection of gastric cancer in a patient with an LVAD.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management

